CHEK1 and cancer: Our study revealed that aberrant glycolytic profiles resulting from increased PGAM1-Chk1 interaction occur in senescent cells, as in cancer cells.23 Posttranscriptional activation of HIF-2α supported enhanced glycolysis in SnCs, whose lactate byproduct also restored the PGAM1-Chk1 interaction.